ProVise Management Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,647
| Closed | -$434K | – | 283 |
|
|
2024
Q3 | $434K | Buy |
3,647
+16
| +0.4% | +$1.91K | 0.03% | 210 |
|
|
2024
Q2 | $518K | Buy |
3,631
+9
| +0.2% | +$1.29K | 0.04% | 178 |
|
|
2024
Q1 | $465K | Hold |
3,622
| – | – | 0.04% | 193 |
|
|
2023
Q4 | $375K | Buy |
3,622
+26
| +0.7% | +$2.69K | 0.03% | 257 |
|
|
2023
Q3 | $327K | Hold |
3,596
| – | – | 0.03% | 265 |
|
|
2023
Q2 | $291K | Hold |
3,596
| – | – | 0.03% | 287 |
|
|
2023
Q1 | $286K | Hold |
3,596
| – | – | 0.03% | 289 |
|
|
2022
Q4 | $243K | Buy |
+3,596
| New | +$243K | 0.02% | 281 |
|
|
2022
Q3 | – | Sell |
-3,596
| Closed | -$200K | – | 332 |
|
|
2022
Q2 | $200K | Hold |
3,596
| – | – | 0.02% | 316 |
|
|
2022
Q1 | $200K | Hold |
3,596
| – | – | 0.02% | 360 |
|
|
2021
Q4 | $201K | Buy |
+3,596
| New | +$201K | 0.02% | 375 |
|
|
2015
Q3 | – | Sell |
-14,696
| Closed | -$402K | – | 290 |
|
|
2015
Q2 | $402K | Sell |
14,696
-25,440
| -63% | -$696K | 0.09% | 198 |
|
|
2015
Q1 | $1.07M | Buy |
40,136
+1,170
| +3% | +$31.3K | 0.23% | 122 |
|
|
2014
Q4 | $825K | Buy |
38,966
+930
| +2% | +$19.7K | 0.18% | 142 |
|
|
2014
Q3 | $909K | Buy |
38,036
+4,686
| +14% | +$112K | 0.2% | 142 |
|
|
2014
Q2 | $768K | Hold |
33,350
| – | – | 0.17% | 160 |
|
|
2014
Q1 | $760K | Buy |
33,350
+1,400
| +4% | +$31.9K | 0.18% | 144 |
|
|
2013
Q4 | $587K | Buy |
31,950
+1,000
| +3% | +$18.4K | 0.15% | 163 |
|
|
2013
Q3 | $525K | Buy |
30,950
+12,300
| +66% | +$209K | 0.15% | 170 |
|
|
2013
Q2 | $291K | Buy |
+18,650
| New | +$291K | 0.09% | 237 |
|